Stocks Health care LIFD
OTC · Health careLftd Partners Inc. (LIFD)
It posted a net loss of $29.9M. Operating cash flow minus capital spending left $1.2M of free cash flow in fiscal 2025. At June 30, 2026 it held $1.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Watch LIFD in 60 secondsWhat Lftd Partners Inc. does
Lftd Partners Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker LIFD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $36.9M | -$24.9M | -$1.68 | $1.2M |
| 2024 | $37.3M | -$1.9M | -$0.13 | -$1.3M |
| 2023 | $51.6M | $2.2M | $0.13 | -$150.7K |
| 2022 | $57.4M | $7.2M | $0.45 | $2.1M |
| 2021 | $31.7M | $5.8M | $0.43 | $5.3M |
| 2020 | $5.3M | -$1.5M | -$0.29 | -$408.2K |
Full financial statements: income, balance sheet and cash flow
Where LIFD ranks in Health care
Dividends
It paid out $11.8K in cash dividends, 0% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2021 | n/a | $11.8K | 0% |
| 2020 | n/a | $15K | n/a |
| 2019 | n/a | $0 | n/a |
Latest SEC filings
What Lftd Partners Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 16% to $8.7M versus the same quarter last year; diluted EPS -$0.10 versus -$0.02.
- July 24, 2026
- June 17, 2026
- May 15, 2026Quarterly report 10-Q · period to March 31, 2026Revenue was flat at $9.2M versus the same quarter last year; diluted EPS -$0.28 versus -$0.02.
- April 1, 2026Annual report 10-K · period to December 31, 2025Revenue fell 1.1% to $36.9M versus the prior year; diluted EPS -$1.68 versus -$0.13.
- April 1, 2026Late annual report notice NT 10-K
- November 14, 2025Quarterly report 10-Q · period to September 30, 2025Revenue rose 4.2% to $9.1M versus the same quarter last year; diluted EPS $0.04 versus -$0.01.
- August 14, 2025
- May 15, 2025
- April 16, 2025Other event 8-K
What is LIFD worth? A DCF from its reported cash flow
Questions about LIFD
What does Lftd Partners Inc. do?
Lftd Partners Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker LIFD.
Is Lftd Partners Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $29.9M.
When did Lftd Partners Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.
Similar companies
Compare LIFD with
Follow LIFD
Get an email when Lftd Partners Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow LIFD: get an email when it filesWhere the numbers come from
Financial figures are the values Lftd Partners Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.